Literature DB >> 20437397

Home sphygmomanometers: what should a nephrologist know?

Tekin Akpolat1.   

Abstract

Inaccuracy of home sphygmomanometers is a common, neglected and often ignored problem. The aims of this review are to emphasize the advantages of self-measurement of blood pressure (BP) at home, to summarize basic features of automated home BP measurement devices, to point out the distinction between validation, calibration and accuracy of home sphygmomanometers and to discuss some practical points for the improvement of BP control in chronic kidney disease (CKD) patients for nephrologists. Four features of automated sphygmomanometers need to be emphasized: measurement site, cuff-size, validation status and accuracy. The validation protocols do not guarantee the accuracy of a particular device for an individual patient. Special patient groups such as those with early stages of CKD or diabetic nephropathy or patients having extraosseous/vascular calcifications may require specific validation tests. Active guidance by nephrologists in all steps of self-measurement of BP at home will improve the control of BP and will increase the quality of patient care in CKD. Health care providers must urgently reimburse the cost of accurate home sphygmomanometers for patients with CKD in countries where CKD is considered a major public health problem.

Entities:  

Mesh:

Year:  2011        PMID: 20437397     DOI: 10.5301/JN.2010.2902

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  2 in total

1.  Chapter 8: Future directions and controversies.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-12

2.  QardioArm Upper Arm Blood Pressure Monitor Against Omron M3 Upper Arm Blood Pressure Monitor in Patients With Chronic Kidney Disease: A Validation Study According to the European Society of Hypertension International Protocol Revision 2010.

Authors:  Victoria Mazoteras-Pardo; Ricardo Becerro-De-Bengoa-Vallejo; Marta Elena Losa-Iglesias; Daniel López-López; David Rodríguez-Sanz; Israel Casado-Hernández; Cesar Calvo-Lobo; Patricia Palomo-López
Journal:  J Med Internet Res       Date:  2019-12-02       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.